Goodman to Exclusively Distribute Embolic Coils from Micrus Endovascular.Tokyo, Japan, Mar 15, 2006 - (JCN JCN Japan Corporate News JCN Journal of Cognitive Neuroscience JCN Journal of Cardiovascular Nursing JCN Journal of Christian Nursing JCN Job Control Number JCN Journal of Child Neurology JCN joint communications network (US DoD) ) - Goodman, a Japanese company involved in the development, manufacture, and distribution of vascular interventional devices, will begin marketing embolic embolic /em·bol·ic/ (em-bol´ik) pertaining to an embolus or to embolism. em·bol·ic adj. 1. Relating to, or caused by an embolus or embolism. 2. Relating to emboly. coils for treating cerebral aneurysms manufactured by US company Micrus Endovascular on April 1. Micrus Endovascular received approval for the devices from the Pharmaceuticals and Medical Devices Agency (PMDA PMDA Plastics Machinery Distributors' Association (United Kingdom) PMDA Plutonium Management and Disposition Agreement (US-Russia) PMDA Pharmaceuticals and Medical Device Agency (Japan) ), an independent administrative agency, on March 1. The devices will be used in a coil embolization embolization /em·bo·li·za·tion/ (em?bo-li-za´shun) 1. the process or condition of becoming an embolus. 2. therapeutic introduction of a substance into a vessel in order to occlude it. procedure for cerebral aneurysms. In Japan, approximately 35,000 people undergo surgery for treatment of cerebral aneurysm each year. Of those surgeries, about 15% utilize coil embolization. Goodman aims to generate 2 billion yen (US $17.0 million) in sales in the first year and 5 billion yen (US $42.3 million) in the third year. Copyright [c] 2006 Japan Corporate News Network. All rights reserved. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion